Exam 2 - Supportive Care Flashcards
highly emetogenic: regimen A
NK-1 antagonist (i.e. aprepitant)
Dexamethasone
5-HT3 antagonist (i.e. ondansetron)
Olanzapine
highly emetogenic: regimen B
Olanzapine
Dexamethasone
5-HT3 antagonist (i.e. ondansetron)
highly emetogenic: regimen C
NK-1 antagonist (i.e. aprepitant)
Dexamethasone
5-HT3 antagonist (i.e. ondansetron)
moderately emetogenic: regimen A
dexamethasone
5-HT3 antagonist (ondansetron)
moderately emetogenic: regimen B
olanzapine
palonosetron
dexamethasone
moderately emetogenic: regimen C
low emetogenic regimens
5-HT3 antagonists: common toxicities
headache, EKG changes (at max doses), constipation
corticosteroids: common toxicities
insomnia, hyperglycemia, increased appetite
highly emetogenic chemotherapy agents
-doxorubicin
-cyclophosphamide
-cisplatin + carboplatin
Anti-emetics are most effective when given as _____________
prophylaxis